Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma [0.03%]
阿霉素治疗晚期尿路上皮癌的男女疗效对比研究
Anishka A D&#x;Souza,Susan G Groshen,Denice Tsao-Wei et al.
Anishka A D&#x;Souza et al.
Purpose: Multiple studies of bladder cancer noted worse outcomes in females compared to males. Few focused on prospective comparisons of sex regarding treatment response, survival, and toxicity. This phase 2 study compare...
Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer [0.03%]
可切除非小细胞肺癌新辅助免疫治疗的进展与展望
Aparna Sharma,Praful Pandey,Swasthik Upadhya et al.
Aparna Sharma et al.
Neoadjuvant immunotherapy has emerged as a cornerstone of therapy for resectable non-small cell lung cancer (NSCLC). Advantages over adjuvant therapy include possibly higher efficacy given the higher neoantigen load and intact lymphatics, t...
BCMA-directed CAR-T cell therapy in relapsed/refractory multiple myeloma: efficacy, safety, survival, and future directions - A systematic review and meta-analysis [0.03%]
靶向BCMA的CAR-T细胞治疗复发/难治性多发性骨髓瘤：疗效、安全性、生存期及未来发展方向——系统评价和Meta分析
Muhammad Shaheer Mannan,Adeena Musheer,Muhammad Waqas Khan et al.
Muhammad Shaheer Mannan et al.
Background: Multiple myeloma is an incurable hematologic malignancy, although therapeutic advances have improved survival. BCMA-directed CAR-T cell therapy has shown high response rates in relapsed or refractory multiple ...
Immune-metabolic plasticity in AML: Prognostic roles of aCTLs (activated Cytotoxic T Cells) and Kynurenine [0.03%]
急性髓系白血病中免疫代谢的可塑性：活化细胞毒性T淋巴细胞和犬尿氨酸的预后作用
Amit Choudhary,Ramya Ramesh,Rakhee Kar et al.
Amit Choudhary et al.
Acute myeloid leukemia (AML), traditionally risk-stratified by genetic abnormalities, is an aggressive malignancy with high relapse and modest survival. Immune dysregulation is an emerging pathogenic mechanism. We investigated cellular immu...
The need for mobile applications in hospital-based cancer registries in India: A framework for ABDM-integrated surveillance [0.03%]
印度基于医院的癌症登记处移动应用程序的需求：ABDM集成监测框架
Prasanna R Deshpande,Sayalee D Kurulekar
Prasanna R Deshpande
Background: Hospital-Based Cancer Registries (HBCRs) are vital for cancer surveillance under India's National Cancer Registry Programme (NCRP). However, most HBCRs rely on retrospective, manual, or semi-digital workflows,...
End-of-induction MRD predicts early survival in high-risk adult B-acute lymphoblastic leukemia: A study from Eastern India [0.03%]
诱导末MRD预测高危成人B淋巴母细胞白血病早期生存：来自印度东部的一项研究
Prakhar Gupta,Meghna Tyagi,Subhajit Brahma et al.
Prakhar Gupta et al.
Measurable residual disease (MRD) monitoring has dramatically improved outcomes in pediatric acute lymphoblastic leukemia (ALL) patients while, the prognosis in adult B-ALL remains poor. Biological heterogeneity, therapy-related toxicity, a...
CAR-T/NK/M-based combination therapies in cancer: A comprehensive review [0.03%]
基于CAR-T/NK/M的肿瘤组合疗法：综述文章
Shivani Vaja,Shubhi Khandelwal,Chaitali Vora et al.
Shivani Vaja et al.
Chimeric Antigen Receptor T (CAR-T) cell therapy, in combination with other treatments or medications, presents a groundbreaking development in cancer immunotherapy. CAR-T immunotherapy has shown remarkable progress, with multiple therapies...
Title: Impact of CYP3A5*3 genetic polymorphism on breast cancer risk: Evidence from Bangladesh [0.03%]
CYP3A5*3基因多态性与乳腺癌风险的相关性：基于孟加拉国的证据
Sm Faysal Bellah,S M Saker Billah
Sm Faysal Bellah
Background: The CYP3A5 gene plays a crucial role in drug metabolism and carcinogen activation, potentially influencing breast cancer susceptibility. However, its genetic association with breast cancer risk in the Banglade...
Successful autologous stem cell transplantation in a case of multiple myeloma with mechanical heart valves [0.03%]
机械心脏瓣膜多发性骨髓瘤患者的自体干细胞移植治疗有效
Isha Shah,Diksha Dev Yadav,Brig Dr Anil Khetrapal et al.
Isha Shah et al.
Electronic symptom monitoring improves chemotherapy dose intensity in neoadjuvant chemotherapy for breast cancer [0.03%]
电子症状监测可提高乳腺癌新辅助化疗的化疗剂量强度
Yuki Takei,Atsufumi Nomoto,Mizuki Kawashima et al.
Yuki Takei et al.
Purpose: The present study investigated the clinical impact of electronic patient-reported outcome (ePRO) monitoring on chemotherapy dose intensities and adverse event (AE) management in patients with early-stage breast c...